TFAP2C expression in breast cancer: correlation with overall survival beyond 10 years of initial diagnosis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TFAP2C expression in breast cancer: correlation with overall survival beyond 10 years of initial diagnosis
Authors
Keywords
TFAP2C, Estrogen receptor, Breast cancer, Outcome
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 152, Issue 3, Pages 519-531
Publisher
Springer Nature
Online
2015-07-09
DOI
10.1007/s10549-015-3492-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PROGgeneV2: enhancements on the existing database
- (2015) Chirayu Pankaj Goswami et al. BMC CANCER
- Estrogen receptor (ER) α mutations in breast cancer: hidden in plain sight
- (2014) Suzanne A. W. Fuqua et al. BREAST CANCER RESEARCH AND TREATMENT
- Sumoylation Pathway Is Required to Maintain the Basal Breast Cancer Subtype
- (2014) Maria V. Bogachek et al. CANCER CELL
- Kinome-wide Functional Screen Identifies Role of PLK1 in Hormone-Independent, ER-Positive Breast Cancer
- (2014) N. E. Bhola et al. CANCER RESEARCH
- Emergence of Constitutively Active Estrogen Receptor- Mutations in Pretreated Advanced Estrogen Receptor-Positive Breast Cancer
- (2014) R. Jeselsohn et al. CLINICAL CANCER RESEARCH
- Delineation of a FOXA1/ER /AGR2 Regulatory Loop That Is Dysregulated in Endocrine Therapy-Resistant Breast Cancer
- (2014) T. M. Wright et al. MOLECULAR CANCER RESEARCH
- TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis
- (2014) A R Cyr et al. ONCOGENE
- Genome-wide activity of unliganded estrogen receptor-α in breast cancer cells
- (2014) Livia Caizzi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis
- (2013) Colin Clarke et al. CARCINOGENESIS
- Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker
- (2013) Dennis C. Sgroi et al. JNCI-Journal of the National Cancer Institute
- ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
- (2013) Weiyi Toy et al. NATURE GENETICS
- Activating ESR1 mutations in hormone-resistant metastatic breast cancer
- (2013) Dan R Robinson et al. NATURE GENETICS
- PLK1 Signaling in Breast Cancer Cells Cooperates with Estrogen Receptor-Dependent Gene Transcription
- (2013) Michael Wierer et al. Cell Reports
- Expression of the RET Proto-oncogene Is Regulated by TFAP2C in Breast Cancer Independent of the Estrogen Receptor
- (2012) Philip M. Spanheimer et al. ANNALS OF SURGICAL ONCOLOGY
- Histone Demethylase KDM5B Collaborates with TFAP2C and Myc To Repress the Cell Cycle Inhibitor p21cip (CDKN1A)
- (2012) P.-P. Wong et al. MOLECULAR AND CELLULAR BIOLOGY
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer
- (2011) Hany Onsy Habashy et al. BREAST CANCER RESEARCH AND TREATMENT
- FOXA1 is an independent prognostic marker for ER-positive breast cancer
- (2011) Rutika J. Mehta et al. BREAST CANCER RESEARCH AND TREATMENT
- AP-2γ regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription
- (2011) Si Kee Tan et al. EMBO JOURNAL
- PBX1 Genomic Pioneer Function Drives ERα Signaling Underlying Progression in Breast Cancer
- (2011) Luca Magnani et al. PLoS Genetics
- Subcellular Localization of Activated AKT in Estrogen Receptor- and Progesterone Receptor-Expressing Breast Cancers
- (2010) Sunil Badve et al. AMERICAN JOURNAL OF PATHOLOGY
- Estrogen-Dependent and Estrogen-Independent Mechanisms Contribute to AIB1-Mediated Tumor Formation
- (2010) M. I. Torres-Arzayus et al. CANCER RESEARCH
- Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells
- (2010) George W. Woodfield et al. GENES CHROMOSOMES & CANCER
- FOXA1 is a key determinant of estrogen receptor function and endocrine response
- (2010) Antoni Hurtado et al. NATURE GENETICS
- FOXA1 in breast cancer
- (2009) Harikrishna Nakshatri et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Genome-Wide Functional Synergy between Amplified and Mutated Genes in Human Breast Cancer
- (2008) Y. Nikolsky et al. CANCER RESEARCH
- The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer
- (2008) M. Schmidt et al. CANCER RESEARCH
- Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance
- (2008) Hany Onsy Habashy et al. EUROPEAN JOURNAL OF CANCER
- Bone metastasis is strongly associated with estrogen receptor–positive/progesterone receptor–negative breast carcinomas
- (2008) Bing Wei et al. HUMAN PATHOLOGY
- Overexpression ofTFAP2Cin invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival
- (2008) JMW Gee et al. JOURNAL OF PATHOLOGY
- Regulation of ERBB2 by oestrogen receptor–PAX2 determines response to tamoxifen
- (2008) Antoni Hurtado et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now